Changes in the brain catecholamines in patients with dementia of Alzheimer type
- PMID: 486847
- DOI: 10.1192/bjp.135.3.216
Changes in the brain catecholamines in patients with dementia of Alzheimer type
Abstract
Brain monoamine concentrations were determined post mortem in 19 patients with dementia of Alzheimer type. Samples were taken from 10 parts of the brain and compared with an age-matched control group. There were lower mean concentrations of dopamine in the demented group of patients in seven regions of the brain, and two of these were at a significant level. There were also significantly lower concentrations of homovanillic acid in the nucleus caudatus and in the putamen. The means of the concentrations of noradrenaline were also lower, and in the putamen and the cortex gyrus frontalis significant differnces were observed. The 5-hydroxytryptamine concentrations were slightly lower in the demented group but the differences did not reach significance. The degree of intellectual deterioration was negatively correlated with the noradrenaline concentrations in the hypothalamus and the cortex gyrus cinguli.
Similar articles
-
Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.Brain Res. 1983 Nov 28;280(1):119-26. doi: 10.1016/0006-8993(83)91179-4. Brain Res. 1983. PMID: 6228286
-
Monoamine metabolism in senile dementia of Alzheimer type.J Neurol Sci. 1983 Aug-Sep;60(3):383-92. doi: 10.1016/0022-510x(83)90149-1. J Neurol Sci. 1983. PMID: 6195313
-
Effects of chlorpromazine on the metabolism of catecholamines in dog brain.Br J Pharmacol. 1969 Jul;36(3):535-48. doi: 10.1111/j.1476-5381.1969.tb08009.x. Br J Pharmacol. 1969. PMID: 5789808 Free PMC article.
-
An update on the neurochemistry of Alzheimer disease.Adv Neurol. 1983;38:75-86. Adv Neurol. 1983. PMID: 6137134 Review. No abstract available.
-
Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment.Psychopharmacology (Berl). 1985;86(3):245-52. doi: 10.1007/BF00432208. Psychopharmacology (Berl). 1985. PMID: 2863836 Review.
Cited by
-
Cerebrospinal fluid catecholamines in Alzheimer's disease patients with and without biological disease.Transl Psychiatry. 2022 Apr 9;12(1):151. doi: 10.1038/s41398-022-01901-5. Transl Psychiatry. 2022. PMID: 35397615 Free PMC article.
-
Ablation of the locus coeruleus increases oxidative stress in tg-2576 transgenic but not wild-type mice.Int J Alzheimers Dis. 2010 Oct 11;2010:864625. doi: 10.4061/2010/864625. Int J Alzheimers Dis. 2010. PMID: 20981353 Free PMC article.
-
Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task.Psychopharmacology (Berl). 2009 Jan;202(1-3):111-23. doi: 10.1007/s00213-008-1334-1. Epub 2008 Oct 7. Psychopharmacology (Berl). 2009. PMID: 18839151
-
Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.Acta Neuropathol Commun. 2017 Jan 21;5(1):8. doi: 10.1186/s40478-017-0411-2. Acta Neuropathol Commun. 2017. PMID: 28109312 Free PMC article.
-
Gene expression of serotonergic markers in peripheral blood mononuclear cells of patients with late-onset Alzheimer's disease.Heliyon. 2020 Aug 24;6(8):e04716. doi: 10.1016/j.heliyon.2020.e04716. eCollection 2020 Aug. Heliyon. 2020. PMID: 32904297 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources